Skip to main content

GSA CAPITAL PARTNERS LLP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1362033 LONDON, X0

Position in IOVA

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,955,368
-$427,881 QoQ
Shares Held
557,085
-36.2% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#52
of 284 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $99,952,720 across 160 Biotechnology names. IOVA ranks #8 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 IOVA
Iovance Biotherapeutics, Inc.
This page
557,085 $1,955,368

All Filings in IOVA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,955,368 557,085
2025-12-31 $2,383,249 872,985
2025-09-30 $171,911 79,222
2025-06-30 $338,164 196,607
2025-03-31 $86,336 25,927
2024-09-30 $242,487 25,824
2024-03-31 $907,354 61,225
2023-03-31 $1,324,538 216,782
2022-12-31 $1,123,317 175,793
2022-09-30 $773,834 80,776
2022-06-30 $1,971,501 178,578
2022-03-31 $280,102 16,823
2021-12-31 $293,947 15,398
2020-12-31 $246,894 5,321